Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ESLA | AZN | AMGN | GILD | BMY |
| Company | Estrella Immunopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.7300 | 205.45 | 345.61 | 140.10 | 58.01 |
| High | 2.1000 | 206.73 | 351.33 | 141.57 | 59.23 |
| Low | 1.6000 | 203.66 | 342.35 | 138.47 | 57.67 |
| Latest | 1.9200 | 204.27 | 349.81 | 141.54 | 59.20 |
| Change | +0.2000 | +3.46 | +9.81 | +2.74 | +1.53 |
| % Change | +11.63% | +1.72% | +2.89% | +1.97% | +2.65% |
| Volume | 593,300 | 2,282,800 | 2,666,400 | 4,967,200 | 11,587,500 |
| 20-Day Average Volume | 173,270 | 1,903,495 | 2,697,785 | 6,103,760 | 13,592,575 |
| Previous Close | 1.7200 | 200.81 | 340.00 | 138.80 | 57.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1743 | 192.60 | 353.84 | 140.32 | 59.08 |
| 20-Day Raw Stochastic | 84.07% | 89.89% | 32.72% | 49.64% | 47.62% |
| 20-Day Relative Strength | 74.85 | 59.84 | 46.07 | 50.83 | 50.58 |
| Weighted Alpha | -7.41 | +53.33 | +22.85 | +36.56 | +23.35 |
| Today's Opinion | 8% Buy | 88% Buy | 40% Buy | 56% Buy | 64% Buy |
| Previous Opinion | 8% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 72% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +81.13% since 03/31/26 | +3.57% since 03/31/26 | -0.58% since 03/31/26 | +1.56% since 03/31/26 | -2.39% since 03/31/26 |
| Low | 1.0100 on 04/01/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 2.1000 on 04/08/26 | 206.73 on 04/08/26 | 357.00 on 04/01/26 | 141.57 on 04/08/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +79.44% since 03/06/26 | +5.17% since 03/06/26 | -5.34% since 03/06/26 | -1.66% since 03/06/26 | -1.81% since 03/06/26 |
| Low | 0.9700 on 03/23/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 2.1000 on 04/08/26 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +35.21% since 01/08/26 | +8.64% since 01/08/26 | +5.97% since 01/08/26 | +17.30% since 01/08/26 | +5.90% since 01/08/26 |
| Low | 0.9002 on 01/22/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 2.1000 on 04/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +47.69% since 10/08/25 | +19.62% since 10/08/25 | +18.73% since 10/08/25 | +19.70% since 10/08/25 | +32.91% since 10/08/25 |
| Low | 0.9002 on 01/22/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 3.1500 on 11/04/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 73,384 | 311,437,824 | 183,283,120 | 172,281,616 | 117,746,848 |
| Shares Outstanding, K | 42,665 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -13,060,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -610,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.58 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 03/17/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.14 | 15.68 | 17.19 | 9.65 |